Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Personalized Mapping of Drug Metabolism by the Human Gut Microbiome

Cell(2020)10.1016/j.cell.2020.05.001Source: DataRank Database

Personalized Mapping of Drug Metabolism by the Human Gut Microbiome is a research paper published in Cell (2020). On theSindex it has a DataRank of 0. It has been cited 468 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access468 citations

Download PDF

Cite:

Linked data & code

bioproject

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 17.22)OA: bronzeTopics (59)Linked Datasets (12)DataCite Reuse (12)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Jaime G Lopez ORCID,Pranatchareeya Chankhamjon ORCID,Ying‐Chiang J. Lee ORCID,Raphaella Hull,Qihao Wu ORCID

Live enrichment

PubMed:32526207 PMC:PMC8591631 OpenAlex:https://openalex.org/W3034548692

National Institutes of Health

Grant: 1DP2AI124441

National Science Foundation

Grant: 2017249408

National Institute of General Medical Sciences

Grant: T32GM007388

NIAID NIH HHS

Grant: DP2 AI124441

Princeton University

FWCI

17.22

Citation Percentile

1.0%

Citation Trend

2019

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cell.com/article/S0092867420305638/pdf

publisherhttp://www.cell.com/article/S0092867420305638/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867420305638?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867420305638?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cell.2020.05.001

Fields of Study

Gut microbiota and healthDiet and metabolism studiesPharmacogenetics and Drug MetabolismAdultAnimalsBacteriaBiomarkers, PharmacologicalDrug Evaluation, PreclinicalFecesFemaleGastrointestinal MicrobiomeHealthy VolunteersHumansMaleMetagenomeMetagenomicsMiceMice, Inbred C57BLMicrobiotaPharmaceutical PreparationsPrecision MedicineRNA, Ribosomal, 16S

MeSH Terms

Gastrointestinal MicrobiomeAdultAnimalsBacteriaDrug Evaluation, PreclinicalPharmaceutical PreparationsFecesFemaleHumansMaleMice, Inbred C57BLRNA, Ribosomal, 16SMiceBiomarkers, PharmacologicalMetagenomeMetagenomicsPrecision MedicineMicrobiotaHealthy Volunteers

Keywords

MicrobiomeBiologyGut microbiomeMetagenomicsComputational biologyContext (archaeology)Drug metabolismDrug developmentPersonalized medicineHuman microbiomeDrugBioinformaticsGeneticsGenePharmacologyMicrobial communityFunctional MetagenomicsDrug-microbiome Interactions

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1

10.6084/m9.figshare.23632666.v1figshare

Additional file 1 of Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1

10.6084/m9.figshare.23632666figshare

Additional file 2 of Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1

10.6084/m9.figshare.23632669.v1figshare

Additional file 2 of Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1

10.6084/m9.figshare.23632669figshare

Additional file 1 of Analysis of metabolites in human gut: illuminating the design of gut-targeted drugs

10.6084/m9.figshare.26626693.v1figshare

Additional file 1 of Analysis of metabolites in human gut: illuminating the design of gut-targeted drugs

10.6084/m9.figshare.26626693figshare

Additional file 2 of Understanding the “individual drug reaction” from the perspective of the interaction between probiotics and lovastatin in vitro and in vivo

10.6084/m9.figshare.26619514.v1figshare

Additional file 2 of Understanding the “individual drug reaction” from the perspective of the interaction between probiotics and lovastatin in vitro and in vivo

10.6084/m9.figshare.26619514figshare

Additional file 1 of Understanding the “individual drug reaction” from the perspective of the interaction between probiotics and lovastatin in vitro and in vivo

10.6084/m9.figshare.26619511.v1figshare

Additional file 1 of Understanding the “individual drug reaction” from the perspective of the interaction between probiotics and lovastatin in vitro and in vivo

10.6084/m9.figshare.26619511figshare

Additional file 1 of Bacteroides salyersiae is a potent chondroitin sulfate-degrading species in the human gut microbiota

10.6084/m9.figshare.25309990figshare

Additional file 1 of Bacteroides salyersiae is a potent chondroitin sulfate-degrading species in the human gut microbiota

10.6084/m9.figshare.25309990.v1figshare